NRX Pharmaceuticals Inc (NRXP NASDAQ) stock market data APIs
$3.3502
-0.07(-2.1%)
as of July 3, 2025
Try our APIs with
free plan!
NRX Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
Prev. Close
3.3502
Open
3.2841
High
3.4059
Low
3.1972
52 wk Range
1.1-6.01
Market Cap
65 921 K
Shares Outstanding
19 503 K
EPS
-0.34
Beta
1.548
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NRX Pharmaceuticals Inc data using free add-ons & libraries
Get NRX Pharmaceuticals Inc Fundamental Data
NRX Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -17 447 750
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-15
- EPS/Forecast: -0.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NRX Pharmaceuticals Inc News
New
HOPE Therapeutics To Buy 49% Stake In Florida Neuropsychiatry Clinic Cohen And Associates
(RTTNews) - HOPE Therapeutics, Inc., a healthcare delivery company and a unit of NRx Pharmaceuticals, Inc. (NRXP) on Thursday said that it has agreed to acquire 49% stake in Cohen and Associates, LLC,...
NRx Pharmaceuticals files $150M mixed shelf offering
* NRx Pharmaceuticals (NASDAQ:NRXP [https://seekingalpha.com/symbol/NRXP]) has filed a shelf registration to offer up to $150M in securities over time. * Securities may include common stock, prefe...
New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NAS
The show is sponsored by The Sustainable Green Team’s (OTC:SG™) Waterless Garden NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / New to The Street, the nation’s leading financial televisi...
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST
Featured as Sponsored Programming: FLOKI, BioVie Inc. (NASDAQ:BIVI), NRX Pharmaceuticals (NASDAQ:NRXP), and Vita Bella NEW YORK CITY, NEW YORK / ACCESS Newswire / June 16, 2025 / New to The Street, a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
